Streetbeat News

Stock Prices

PSHG

Sphinx Investment has extended the expiration date of its offer to purchase Performance Shipping (PSHG) for $3.00 per share in cash. The new expiration date is 11:59 P.M., New York City Time, on September 17.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 10:59 am

TH

Target Hospitality has revised its FY24 total revenue outlook downwards from $410M-$425M to $375M-$385M, below the estimated $396.10M. This revision follows the termination of the STFRC Contract and other factors.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 10:58 am

COIN

FBTC

GBTC

Bitcoin spot ETFs saw a net inflow of $21.5187 million on June 26, with significant contributions from Fidelity ETF (FBTC) and Grayscale ETF (GBTC). Despite this, the cryptocurrency market remains anxious. The U.S. government transferred 3,940 BTC to Coinbase Prime (COIN), and the German government has slowed its BTC transfers to exchanges. Analysts suggest the market may have priced in potential sell-offs, leading to strategies for accumulating Bitcoin.

Portfolio Pulse from Murtuza Merchant

June 27, 2024 | 10:51 am

LNN

Lindsay (NYSE:LNN) reported Q3 2024 GAAP EPS of $1.85, beating the estimate of $1.17 by 58.12%. However, sales were $139.2M, missing the $144.363M estimate and showing a 15.41% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 10:48 am

APOG

Apogee Enterprises has raised its FY25 adjusted EPS guidance to a range of $4.65 to $5.00, up from the previous range of $4.35 to $4.75. This is above the consensus estimate of $4.52.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 10:47 am

HUT

Hut 8 Corp. (Nasdaq: HUT), a major Bitcoin miner, will join the Russell 3000 Index at the conclusion of the 2024 Russell U.S. Indexes annual reconstitution, effective July 1, 2024. This inclusion is based on market capitalization rankings as of April 30, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 10:36 am

ZOM

Zomedica Corp. (NYSE:ZOM) has launched a new cortisol assay for equine health on its TRUFORMA diagnostic platform. This new tool allows equine veterinarians to measure cortisol levels in foals at the point of care, enabling real-time, potentially life-saving treatment decisions. The TRUFORMA platform addresses a $1.5 billion annual recurring revenue opportunity in the US and is expanding into the European market.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 10:35 am

MU

Micron Technology's stock dropped over 5% in pre-market trading despite beating Q3 revenue and EPS estimates. The decline is attributed to minor profit booking. The company's AI prospects remain strong, with expected growth in High Bandwidth Memory (HBM) revenue. Micron is also set to benefit from the CHIPS Act.

Portfolio Pulse from Benzinga Neuro

June 27, 2024 | 10:33 am

XFOR

X4 Pharmaceuticals announced new clinical data from its ongoing Phase 2 trial of mavorixafor for chronic neutropenia, showing the drug was generally well tolerated and durably increased participants' absolute neutrophil counts. 100% of evaluable participants at Month 6 achieved target ANC increase.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 10:33 am

NVDA

AI-related cryptocurrencies Fetch.ai (FET), SingularityNET (AGIX), and Ocean Protocol (OCEAN) have outperformed Bitcoin and Ethereum over the past week, driven by excitement around a token merger to create the Artificial Superintelligence Alliance (ASI) token. Despite Nvidia's recent decline in stock price, these AI-linked cryptos have continued to rise.

Portfolio Pulse from Aniket Verma

June 27, 2024 | 10:32 am